The Anti-Microbial Peptide (Lin-SB056-1)<sub>2</sub>-K Reduces Pro-Inflammatory Cytokine Release through Interaction with <i>Pseudomonas aeruginosa</i> Lipopolysaccharide

The ability of many anti-microbial peptides (AMPs) to modulate the host immune response has highlighted their possible therapeutic use to reduce uncontrolled inflammation during chronic infections. In the present study, we examined the anti-inflammatory potential of the semi-synthetic peptide lin-SB...

Full description

Bibliographic Details
Main Authors: Lucia Grassi, Arianna Pompilio, Esingül Kaya, Andrea C. Rinaldi, Enrico Sanjust, Giuseppantonio Maisetta, Aurélie Crabbé, Giovanni Di Bonaventura, Giovanna Batoni, Semih Esin
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/9/585
_version_ 1797554350746238976
author Lucia Grassi
Arianna Pompilio
Esingül Kaya
Andrea C. Rinaldi
Enrico Sanjust
Giuseppantonio Maisetta
Aurélie Crabbé
Giovanni Di Bonaventura
Giovanna Batoni
Semih Esin
author_facet Lucia Grassi
Arianna Pompilio
Esingül Kaya
Andrea C. Rinaldi
Enrico Sanjust
Giuseppantonio Maisetta
Aurélie Crabbé
Giovanni Di Bonaventura
Giovanna Batoni
Semih Esin
author_sort Lucia Grassi
collection DOAJ
description The ability of many anti-microbial peptides (AMPs) to modulate the host immune response has highlighted their possible therapeutic use to reduce uncontrolled inflammation during chronic infections. In the present study, we examined the anti-inflammatory potential of the semi-synthetic peptide lin-SB056-1 and its dendrimeric derivative (lin-SB056-1)<sub>2</sub>-K, which were previously found to have anti-microbial activity against <i>Pseudomonas aeruginosa</i> in in vivo-like models mimicking the challenging environment of chronically infected lungs (i.e., artificial sputum medium and 3-D lung mucosa model). The dendrimeric derivative exerted a stronger anti-inflammatory activity than its monomeric counterpart towards lung epithelial- and macrophage-cell lines stimulated with <i>P. aeruginosa</i> lipopolysaccharide (LPS), based on a marked decrease (up to 80%) in the LPS-induced production of different pro-inflammatory cytokines (i.e., IL-1β, IL-6 and IL-8). Accordingly, (lin-SB056-1)<sub>2</sub>-K exhibited a stronger LPS-binding affinity than its monomeric counterpart, thereby suggesting a role of peptide/LPS neutralizing interactions in the observed anti-inflammatory effect. Along with the anti-bacterial and anti-biofilm properties, the anti-inflammatory activity of (lin-SB056-1)<sub>2</sub>-K broadens its therapeutic potential in the context of chronic (biofilm-associated) infections.
first_indexed 2024-03-10T16:29:46Z
format Article
id doaj.art-83e0cef3acad4a7e96531fd5491858db
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T16:29:46Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-83e0cef3acad4a7e96531fd5491858db2023-11-20T12:54:47ZengMDPI AGAntibiotics2079-63822020-09-019958510.3390/antibiotics9090585The Anti-Microbial Peptide (Lin-SB056-1)<sub>2</sub>-K Reduces Pro-Inflammatory Cytokine Release through Interaction with <i>Pseudomonas aeruginosa</i> LipopolysaccharideLucia Grassi0Arianna Pompilio1Esingül Kaya2Andrea C. Rinaldi3Enrico Sanjust4Giuseppantonio Maisetta5Aurélie Crabbé6Giovanni Di Bonaventura7Giovanna Batoni8Semih Esin9Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa PI, ItalyDepartment of Medical, Oral and Biotechnological Sciences, and Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti CH, ItalyDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa PI, ItalyDepartment of Biomedical Sciences, University of Cagliari, 09142 Monserrato CA, ItalyDepartment of Biomedical Sciences, University of Cagliari, 09142 Monserrato CA, ItalyDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa PI, ItalyLaboratory of Pharmaceutical Microbiology, Ghent University, 9000 Gent, BelgiumDepartment of Medical, Oral and Biotechnological Sciences, and Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, 66100 Chieti CH, ItalyDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa PI, ItalyDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa PI, ItalyThe ability of many anti-microbial peptides (AMPs) to modulate the host immune response has highlighted their possible therapeutic use to reduce uncontrolled inflammation during chronic infections. In the present study, we examined the anti-inflammatory potential of the semi-synthetic peptide lin-SB056-1 and its dendrimeric derivative (lin-SB056-1)<sub>2</sub>-K, which were previously found to have anti-microbial activity against <i>Pseudomonas aeruginosa</i> in in vivo-like models mimicking the challenging environment of chronically infected lungs (i.e., artificial sputum medium and 3-D lung mucosa model). The dendrimeric derivative exerted a stronger anti-inflammatory activity than its monomeric counterpart towards lung epithelial- and macrophage-cell lines stimulated with <i>P. aeruginosa</i> lipopolysaccharide (LPS), based on a marked decrease (up to 80%) in the LPS-induced production of different pro-inflammatory cytokines (i.e., IL-1β, IL-6 and IL-8). Accordingly, (lin-SB056-1)<sub>2</sub>-K exhibited a stronger LPS-binding affinity than its monomeric counterpart, thereby suggesting a role of peptide/LPS neutralizing interactions in the observed anti-inflammatory effect. Along with the anti-bacterial and anti-biofilm properties, the anti-inflammatory activity of (lin-SB056-1)<sub>2</sub>-K broadens its therapeutic potential in the context of chronic (biofilm-associated) infections.https://www.mdpi.com/2079-6382/9/9/585anti-microbial peptidedendrimeric peptide<i>Pseudomonas aeruginosa</i>LPSanti-inflammatory activity
spellingShingle Lucia Grassi
Arianna Pompilio
Esingül Kaya
Andrea C. Rinaldi
Enrico Sanjust
Giuseppantonio Maisetta
Aurélie Crabbé
Giovanni Di Bonaventura
Giovanna Batoni
Semih Esin
The Anti-Microbial Peptide (Lin-SB056-1)<sub>2</sub>-K Reduces Pro-Inflammatory Cytokine Release through Interaction with <i>Pseudomonas aeruginosa</i> Lipopolysaccharide
Antibiotics
anti-microbial peptide
dendrimeric peptide
<i>Pseudomonas aeruginosa</i>
LPS
anti-inflammatory activity
title The Anti-Microbial Peptide (Lin-SB056-1)<sub>2</sub>-K Reduces Pro-Inflammatory Cytokine Release through Interaction with <i>Pseudomonas aeruginosa</i> Lipopolysaccharide
title_full The Anti-Microbial Peptide (Lin-SB056-1)<sub>2</sub>-K Reduces Pro-Inflammatory Cytokine Release through Interaction with <i>Pseudomonas aeruginosa</i> Lipopolysaccharide
title_fullStr The Anti-Microbial Peptide (Lin-SB056-1)<sub>2</sub>-K Reduces Pro-Inflammatory Cytokine Release through Interaction with <i>Pseudomonas aeruginosa</i> Lipopolysaccharide
title_full_unstemmed The Anti-Microbial Peptide (Lin-SB056-1)<sub>2</sub>-K Reduces Pro-Inflammatory Cytokine Release through Interaction with <i>Pseudomonas aeruginosa</i> Lipopolysaccharide
title_short The Anti-Microbial Peptide (Lin-SB056-1)<sub>2</sub>-K Reduces Pro-Inflammatory Cytokine Release through Interaction with <i>Pseudomonas aeruginosa</i> Lipopolysaccharide
title_sort anti microbial peptide lin sb056 1 sub 2 sub k reduces pro inflammatory cytokine release through interaction with i pseudomonas aeruginosa i lipopolysaccharide
topic anti-microbial peptide
dendrimeric peptide
<i>Pseudomonas aeruginosa</i>
LPS
anti-inflammatory activity
url https://www.mdpi.com/2079-6382/9/9/585
work_keys_str_mv AT luciagrassi theantimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT ariannapompilio theantimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT esingulkaya theantimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT andreacrinaldi theantimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT enricosanjust theantimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT giuseppantoniomaisetta theantimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT aureliecrabbe theantimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT giovannidibonaventura theantimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT giovannabatoni theantimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT semihesin theantimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT luciagrassi antimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT ariannapompilio antimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT esingulkaya antimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT andreacrinaldi antimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT enricosanjust antimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT giuseppantoniomaisetta antimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT aureliecrabbe antimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT giovannidibonaventura antimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT giovannabatoni antimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide
AT semihesin antimicrobialpeptidelinsb0561sub2subkreducesproinflammatorycytokinereleasethroughinteractionwithipseudomonasaeruginosailipopolysaccharide